Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrent Platinum Resistant Ovarian Cancer 1Rectal Neoplasms 1Neoplasm Metastasis 1Colorectal Neoplasms 1Carcinoma 1Adenoviridae Infections 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Interventional × enadenotucirev × Clear all
NCT03916510 2025-02-06

CEDAR

University of Oxford

Phase 1 Completed
12 enrolled 13 charts
Gastrointestinal

Adenoviridae Infections, Rectal Neoplasms

NCT02636036 2021-11-09

SPICE

Akamis Bio

Phase 1 Completed
51 enrolled
GastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT02028117 2021-05-13

OCTAVE

Akamis Bio

Phase 1 Completed
38 enrolled
Gynecologic

Recurrent Platinum Resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡